GINSENOSIDE RE
Ginsenoside B2,\b-D-Glucopyranoside, (3.\b.,6.\a.,12.\b.)-20-(.\b.-D-glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl 2-O-(6-deoxy-.\a.-L-mannopyranosyl)-
GINSENOSIDE RE 列于欧盟 CosIng 清单,但本页尚未关联任何直接的附件记录。
按市场划分的监管证据
此处跟踪的 13 个市场均未导入该成分的规则。
这描述的是本清单,而非法律。没有已导入的规则并不能证明某成分获准使用:规则可能以其他名称或标识符存在,或存在于尚未在此导入的数据集中。
GINSENOSIDE RE 的清单详情
INCI 名称
GINSENOSIDE RE
说明
Ginsenoside B2,\b-D-Glucopyranoside, (3.\b.,6.\a.,12.\b.)-20-(.\b.-D-glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl 2-O-(6-deoxy-.\a.-L-mannopyranosyl)-
GINSENOSIDE RE 的附件记录
关键数据
- ANTIOXIDANT
Inhibiting reactions promoted by oxygen, thus avoiding oxidation and rancidity.
- HUMECTANT
Retaining and/or preserving the moisture in a product during use.
- SKIN CONDITIONING
Maintaining the skin in good condition.
化学身份与性质

Ginsenoside Re
Ginsenoside Re is a ginsenoside found in Panax ginseng that is dammarane which is substituted by hydroxy groups at the 3beta, 6alpha, 12beta and 20 pro-S positions, in which the hydroxy groups at positions 6 and 20 have been converted to the corresponding alpha-L-rhamnopyranosyl-(12)-beta-D-glucopyranoside and beta-D-glucopyranoside respectively, and in which a double bond has been introduced at the 24-25 position. It has a role as an antioxidant, an antineoplastic agent, a neuroprotective agent, an anti-inflammatory agent, a nephroprotective agent and a plant metabolite. It is a 3beta-hydroxy-4,4-dimethylsteroid, a beta-D-glucoside, a tetracyclic triterpenoid, a 3beta-hydroxy steroid, a 12beta-hydroxy steroid, a disaccharide derivative and a ginsenoside. It derives from a hydride of a dammarane. — ChEBI
- IUPAC 名称
- (2S,3R,4R,5R,6S)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[(2S)-6-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-methyloxane-3,4,5-triol
- 分子式
- C48H82O18
- 分子量
- 947.2 g/mol
- 精确质量
- 946.55011576 Da
- XLogP3
- 1.6
- 拓扑极性表面积
- 298.0 Ų
- 氢键供体
- 12
- 氢键受体
- 18
- 共价单元
- 1
- 已定义的立体中心
- 26
又称
另有 16 个已报告名称
外部数据库标识符
- ChEBI:CHEBI:77148
- ChEMBL:CHEMBL510095
- EPA DTXSID:DTXSID801317298
- PubMed:39798073
- PubMed:37308051
- PubMed:36682417
- PubMed:29467000
- PubMed:29037473
- PubMed:25523949
- PubMed:25297453
- PubMed:24781185
- PubMed:24709919
- PubMed:24658813
- PubMed:24615935
- PubMed:24599032
于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。
欧盟官方成分名称证据
该成分名称与 2025 年欧盟官方通用成分名称词汇表完全匹配。
相关清单证据
配方功能重叠的成分
其他官方和科学来源
11 个可用于核查此身份的外部数据库
每个链接都会在该来源中搜索此身份。 各来源是什么及其法律效力
GINSENOSIDE RE 在 CosIng 清单中的呈现方式
CosIng 清单将 GINSENOSIDE RE 列为化妆品成分,本页将其关联到 0 条附件记录。清单条目记录名称和标识符,而附件记录显示该物质在欧盟化妆品法规中被禁用、限用或列入准用清单的情况。
在官方数据中,GINSENOSIDE RE 还被标记了 3 项化妆品功能。功能标识描述预期用途,但不能取代在配方或标签工作之前对关联附件记录的监管审查。